Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Benelux Stocks: Mediq, DSM, Galapagos, KBC Shares Are Active

The Netherlands’ AEX-Index added less than 0.1 percent to 352.05 at the 5:30 p.m. close in Amsterdam, the highest level since April 26. Belgium’s Bel20 Index dropped 0.7 percent to 2,596.59 today.

The following were among the most active stocks in Benelux markets today. Symbols are in parentheses.

Dutch stocks:

Mediq NV (MEDIQ NA) fell 3.8 percent to 13.98 euros, the biggest drop in more than ten months. The largest Dutch pharmacy chain had its recommendation lowered to “hold” from ‘buy” at ING Groep NV.

Royal DSM NV (DSM NA) advanced 3.2 percent to 41 euros, rising for a fourth day. The world’s biggest vitamin maker sold half its penicillin unit to Sinochem Group for 210 million euros ($279 million), ending its six-year search for a partner.

The Dutch company will book a one-off gain of 55 million euros in the fourth quarter, the Heerlen, Netherlands-based company said in a statement.

Belgian stocks:

Galapagos NV (GLPG BB) rose 0.8 percent to 12.17 euros, the highest price in almost two months. The Belgian drug developer extended its contract with Amgen Inc. until 2012. Galapagos will receive 2 million euros in research fees for the first year.

KBC Groep NV (KBC BB), the Belgian bank with 17.4 billion euros of loans in Ireland, fell 4.1 percent to 26.45 euros, the lowest closing price since October 2009. Lloyds Banking Group Plc said it expects an additional 10 percent of its 26.7 billion pounds of loans in the country will be classified as impaired before the fiscal year-end.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.